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T  lymphocytes represent an extraordinarily heterogeneous population of cells with 
respect to antigen receptors, differentiation antigens, and distinct immunologic func- 
tions. Because of this heterogeneity, it is of obvious advantage in many studies to use 
restricted and homogeneous T  cell populations.  Recently, two approaches to isolate 
homogeneous  clones  of T  lymphocytes  have  become  feasible.  One  of them  takes 
advantage of the observation that T  lymphocytes can be maintained and propagated 
in  vitro by culture  in  media containing  the T  cell  growth  factor interleukin  2  (1). 
Although this technique allows for the growth of clones of T  cells with distinct helper, 
suppressor, or cytotoxic properties (2-4), the clones remain absolutely dependent on 
interleukin 2, and large numbers of cells are difficult to generate. The second approach 
uses techniques similar in principle to those defined by Kohler and Milsteiu  (5)  for 
the  production  of monoclonal  antibodies.  This  technology  has  been  developed  in 
murine systems where a number of investigators have created T  cell hybrids by fusing 
normal  murine T  cells with  continuously  growing, aminopterin-sensitive murine T 
lymphoma cell  lines.  Some of these  hybrids  express  phenotypic  properties of both 
parental ceils and, in many instances, they have exhibited functional properties of the 
mature fusion partners (6-13). 
In the experiments to be reported below, we have extended this latter technology 
to human T  cells.  First,  we established 6-thioguanine  (TG)l-resistant, aminopterin- 
sensitive mutants  from the  continuously  growing human  T  cell  line  CEM.  One of 
these mutant T  cell lines (CEM-T15) was fused with lectin-stimulated human T  cells 
and, after selection in medium containing hypoxanthine, aminopterin, and thymidine 
(HAT), T cell hybrids were obtained. These human T cell hybrids grow independently 
from any added  T  cell  growth  factor(s).  Some of these hybrids express the OKT3 
antigen that  is found on normal T  cells but  not on immature thymocytes or on the 
CEM-T15  mutant  line  (14).  Functional  analysis demonstrated  that  many of these 
human T  cell hybids exhibit helper function  in vitro.  Several of these helper T  cell 
hybrids have been cloned repeatedly and maintain helper function. 
Materials and Methods 
Generation of TG-resistant  Mutants.  To  increase  the  frequency of mutants,  the  human  T 
lymphoblastoid line CEM was exposed to the mutagen ethyl methanesulfonate (EMS,  Sigma 
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1  Abbreviations used in this paper:  EMS,  ethyl methanesulfonate; HAT, hypoxanthine-aminopterin-thy- 
midine; HGPRT, hypoxanthine guanine phosphoribosyl  transferase; IMDM, Iscove's  modified Dulbecco's 
medium; PEG, polyethylene  glycol; PFC, plaque-forming  cells; PHA, phytohemagglutinin; PWM, poke- 
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Chemical Co.,  St.  Louis,  Mo.)  (15). Thus,  CEM  cells  growing in exponential phase  at  a 
concentration of 5 ×  105 cells/ml were cultured with EMS at concentrations ranging from 5 to 
160/zg/ml. The cultures were carried out for  16 h in a humidified 95% air, 5% CO2 incubator 
at  370C.  Only 20% of the cells incubated with 5 and  10 #g/ml survived the treatment. At 
higher concentrations of EMS there were no surviving cells. The viable cells  were washed, 
resuspended in final medium containing 7.5 ×  10  -6 M  TG, and plated in microwells.  Final 
medium consisted of Iseove's Modified Dulbeeeo's Medium (IMDM) medium (Gibco Labora- 
tories,  Grand  Island  Biological  Co.,  Grand  Island,  N.  Y.)  with  20%  horse  serum  (Flow 
Laboratories, Roekville, Md.) and 50 #g/ml of chlortetracycline (Gihco Laboratories). Approx- 
imately 60% of the wells showed evidence of growth in this initial concentration of TG. 16 of 
those cultures were expanded to 25-cm  2 flasks and the concentration of TG was increased to 3 
×  10  -5 M. Only 13 of the cultures survived. One of them, CEM-T15, was selected  because of 
excellent growth characteristics. The rest  were frozen and stored in a liquid nitrogen freezer. 
The mutant CEM-T15 has a doubling time of ~22 h and has been steadily growing for >40 
wk. At present, it is growing in medium containing 10  -4 M TG. 
Lymphocyte Preparation and  Fractionation.  Fresh  peripheral  blood  mononuclear cells  were 
isolated from healthy human volunteers by Ficoll-diatrizoate density gradient centrifugation. 
Highly enriched populations ofT and B lymphocytes were obtained by E rosetting and passage 
through a Sephadex G-200 rabbit anti-human F(ab')2 column, as described (16). The B cells 
were treated with the  monoclonal antibody OKT3 plus complement in order to eliminate 
residual T  cells. Alternatively, B cells were obtained from tonsillar lymphocytes by E rosetting 
and subsequent treatment of the E- population with OKT3 antibody plus complement. The 
OKT4  + cells were obtained by negative selection using complement-mediated lysis of the T cell 
population by the OKT8 monoclonal antibody as previously described (17). 
Fusion Procedure.  Human T  lymphocytes at  a  concentration of 2  ×  106  cells/mi were 
incubated with either 10 #g/ml of phytohemmaglutinin (PHA, Gibco Laboratories); 5 #g/mi 
of pokeweed mitogen (PWM, Gibco Laboratories); or 2 #g/ml ofconcanavalin  A (Con A, Miles 
Laboratories Inc., Elkhart, Ind.) in a  5% CO2 humidified atmosphere at  37°C for different 
lengths of time (see Results). These activated T  cells were fused with the TG-resistant CEM- 
T15 mutant using either of two fusion techniques. I.  Activated T cells and CEM-T15 mutants 
were mixed at ratios of 10: t  to 2:1. The mixture was centrifuged and the pellet resuspended 
over a period of 2 min in 1 ml of polyethylene glycol solution (PEG, J. T. Baker Chemical Co., 
Phillipsburg, N. J.). The suspension was then gradually diluted to 50 ml over the course of 10 
min and centrifuged at 250 g for 10 min (6, 18). II.  The pelleted cell mixture was resuspended 
in PEG and immediately spun down for 3 min at 580 g. Without removing the PEG, the cells 
were resuspended in 5 ml of medium and centrifuged at 250 g for 10 min (19). This resulted in 
a  longer time of exposure to PEG than in technique I  (8 vs.  2 min). Both procedures were 
performed at 37°C with prewarmed, serum-free IMDM. Solutions of PEG at different concen- 
trations were adjusted to pH 8.2 immediately before use (20). After fusion by either technique, 
the cells  were washed  twice and resuspended in final medium containing HAT at  various 
concentrations (see Results). The cells were cultured in microtiter plates at a concentration of 
4  ×  104-10 ×  104 mutant cells/well in 0.2  ml. The cultures were maintained at 37°C in a 
humidified 95% air, 5% CO2 incubator and were fed every 5-6 d. 
Surface Antigens Analysis.  Phenotypic cell surface analysis was performed by indirect immu- 
nofluorescence using the monoclonal antibody OKT3 and a fluorescein-conjugated goat anti- 
mouse F(ab')2 antibody (N.  L. Cappel Laboratories Inc., Coehranville, Pa.). The cells were 
analyzed on a cytofluorograf (model 30-H, Ortho Instruments, Westwood, Mass.) as previously 
described (21). A cell  population was considered positive if >20% of the cells expressed  the 
OKT3 antigen. All experiments included a negative ascites control. 
Chromosome Analysis.  Chromosome  preparations  were  performed  according  to  standard 
techniques (22). Briefly, 4 ×  106 exponentially growing cells were cultured with 0.01 p.g/ml of 
Coleemid (Gibco Laboratories). After 2 or 3 h incubation,  the cells were centrifuged and treated 
with 0.075 M potassium chloride for 12 min and then fixed with methanol/glacial acetic acid, 
3:1.  Drops of the fixed  cell suspension were allowed to dry on slides  and were stained with 
Giemsa for microscopic examination. 
Polyclonal Induction of Antibody-secreting Cells.  The culture conditions  and the reverse hemolytic IRIGOYEN  ET  AL.  1829 
plaque  assay  for  the  assessment of induction  and  regulation  of  plaque-forming  cell  (PF(3) 
generation  was previously described  in detail (17).  In brief, 108 B cells were suspended in  1 ml 
of final  medium  containing  5 #g of PWM and  were cultured  in  16 ×  150-mm tissue culture 
tubes. To these tubes were added 105 of either normal T  cells or the different cell hybrids to be 
tested. Control cultures consisted of B ceils cultured alone or in the presence of PWM without 
added T  cells. All cultures were incubated for 5-6 d  in a  humidified 5% (302  incubator at 
37°(3, and then  assayed  for antibody  production  usingsthe  reverse  hemolytic  plaque  assay as 
described (17). The results are expressed as PFC per 10  B cells at the beginning of culture. 
Results 
Differential Growth of CEM vs. CEM- TI 5 in Selective Media.  The TG-resistant mutant 
CEM-TI5 was compared with the parent line CEM for growth in medium containing 
3  X  10  -s M  TG (Fig.  1). As expected. CEM-T15  maintained  vigorous growth in TG 
medium, whereas CEM died within 24-48 h. These results demonstrate that, relative 
to the parental line CEM, CEM-T15  is unable to incorporate TG. These data suggest 
that  CEM-T15  is  deficient  in  hypoxanthine-guanine  phosphoribosyl  transferase 
(HGPRT).  This was further tested  by directly comparing  the mutant  and parental 
CEM  lines for growth in HAT medium.  Under conditions of aminopterin  blockade 
of the de novo purine synthetic pathways, only those cells with HGPRT activity will be 
able  to  incorporate  hypoxanthine  and,  therefore, survive.  In  these experiments,  the 
cells were grown in graded concentrations of aminopterin while the concentrations of 
hypoxanthine  (10  -4 M)  and thymidine  (3  X  10  -5)  were kept  constant.  As shown in 
Fig.  2,  at  an  aminopterin  concentration  of  10  -s  M  both  cell  lines  grow  normally, 
whereas at a concentration of 10  -7 M both cell lines rapidly die. Importantly, however, 
a  differential  growth was observed at aminopterin  concentrations  of 3.3  X  10  -~ and 
6.6  X  10  -S  M.  Under  these  conditions,  CEM-T15  cells die  rapidly  (within  1-4  d), 
whereas  CEM  cells  survive  at  least  7-10  d.  These  data,  taken  together  with  the 
differential  growth  in  TG  medium,  confirm  that  CEM-T15  relative  to  CEM  is 
deficient in HGPRT activity. 
Hybridization  of Activated Human T  Cells  with  the Aminopterin-sensitive Human Lympho- 
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Fxc.  1.  Differential growth of CEM  (0) and CEM-T15  ((3) cells in medium containing 3 ×  10  -5 
M  TG.  The cells were grown at 4 ×  105 cells/ml and the viable cell concentration  was adjusted 
every 2 d. 
Fro.  2.  Differential growth of CEM (0) and CEM-T15 (O) cells in medium containing HAT. The 
cells were grown at 4 x  l0  s cells/ml and the viable cell concentration  was adjusted every 2-3 d. 
Hypoxanthine  (10  -4  M)  and  thymidine  (3  ×  10  -5  M)  concentrations  were  the  same  in  all 
experiments, whereas the concentration ofaminopterin was: (A)  10  -s M; (B) 3.3 x  10  -s M; (C) 6.6 
×  10  -8 M;  (D)  10  -7 M. 1830  GENERATION OF  FUNCTIONAL HUMAN T CELL HYBRIDS 
blastoid T  Cell Line CEM-T15.  The differential  aminopterin sensitivity of CEM-T15 
shown in the preceding experiments suggested that this mutant would be a  suitable 
partner for fusion in hybridization procedures. Fusions of lectin-activated normal and 
leukemic T  cells with CEM-T15  cells were  performed  under different  experimental 
conditions.  To  date,  15  fusions  successfully  generated  cultures  containing  rapidly 
dividing cells (Table I). In these fusion experiments the highest number of wells with 
growing cells was obtained when the fusions were performed according to technique 
II using PEG  1,000 mol wt at 50% concentration. A single fusion with PEG 6,000 mol 
wt  at  40%  concentration using technique I  also yielded  a  high number of growing 
cultures. The chosen HAT concentrations and lengths of exposure of the fused cells to 
HAT  were  derived  from  experiments  comparing  CEM  and CEM-T15  for survival 
under different  concentrations and lengths of incubation in HAT medium  (Fig.  2). 
We  would emphasize  that  using technique  II  with  50%  PEG  1,000  mol  wt  as  the 
fusing  agent,  successful  hybridization  with  a  high  number  of  growing  wells  was 
obtained in all experiments. 
Since growth of ceils in HAT medium  following fusion does not necessarily imply 
successful hybridization, we randomly screened growing wells from all  15 fusions for 
the presence  of cells  expressing  the OKT3  surface  antigen.  This  screening  strategy 
was selected because, in contrast to normal T cells or the leukemic T cells used, CEM- 
T15  cells  lack the OKT3  antigen.  As shown in Table  I,  a  significant  proportion of 
cultures growing 5-7 wk after fusion contain OKT3-positive cells. The data strongly 
suggest  that  the  growing  cells  represent  T  cell  hybrids  since  CEM-T15  does  not 
express OKT3 and the majority of normal or leukemic T  cells would not be rapidly 
dividing after 5-7 wk in culture. 
TABLE  I 
Characteristics of Fusions between Activated Human T Cells and the Aminopterin-sensitive 
T Cell Line CEM-T15 
Activated parental T  cell  PEG  HAT 
Wells 
Fusion  Fusion  Viability  Wells  Wells  with 
hum-  tech-  after fu-  Amiuop- 
mol  Concen-  seeded  growin~  OKT3  ÷ 
her  Type  Lectin  Time  nique*  sion:~  terin con-  Days 
wt  tration  centration  cell~l[ 
'7,  %  M  %  '~ 
8  Normal  PWM  8 d  1,000  35  I1  60  3.3  X  10  a  7  98  4  0 
21  Normal  PHA  4 d  1,000  50  I  >75  3.3  x  10  8  5  180  16  20 
22  Normal  PHA  4 d  1,000  50  1  >75  3.3  x  10  8  5  240  12  40 
23  Normal  PHA  4 d  6,000  40  l  >75  3.3  x  10  -8  5  180  >83  25 
24  Normal  PHA  4 d  1,000  35  1  >75  3.3 x  10 -a  5  240  2.5  0 
25  Normal  PHA  4 d  1,000  35  I1  >75  3.3  ×  10  8  5  240  25  0 
26  Normal  PHA  4 d  1,000  50  II  25  3.3  x  10  a  5  240  >83  55 
27  Normal  PHA  4 d  1,000  50  [!  20  3.3 ×  10  -8  5  240  >83  60 
36  Normal  Con A  2 d  1,000  40  1  70  2.0 ×  10  a  14  300  0  0 
37  Normal  PHA  4 d  1,000  40  I  70  2.0  ×  10  a  14  300  5  10 
38  Normal  PHA  4 d  1,000  40  1  70  2.0 ×  10  -A  14  300  0  0 
43  Leukemic  PHA  12 h  1,00O  50  II  60  3.3  ×  10  -8  7  158  41  23 
44  l~eukemic  PHA  12 h  1,000  50  II  60  3.3 ×  10  s  9  98  :23  27 
45  Leukemic  PHA  12 h  t,00~5  50  II  60  6~6 ×  10  a  5  98  I2  36 
46  Leukemic  PHA  6 h  1,000  5(.I  II  65  3.3 ×  10  s  7  130  45  3I 
47  Leukemic  PHA  6 h  1,000  50  tI  65  3.3  ×  10  -8  9  158  27  29 
48  Leukemic  PHA  6 h  t,00O  50  I[  65  6.6 ×  10  s  5  98  13  15 
* See Methods. 
~: Assessed  by trypan blue exclusion 
§ Assessed  5 wk after fusion. 
I{ Analyzed  by immunofluorescence  in a  cytofluorograf 5.7 wk after fusion. IRIGOYEN ET AL.  1831 
To obtain further evidence for hybridization, samples from fusions 23-27 were also 
analyzed for chromosome number.  When screened  10 wk after fusion, 90% of these 
cultures contained polyploid cells  (range:  60-95  chromosomes), whereas  the CEM 
and CEM-T15 lines contained diploid cells (range: 35-47 chromosomes). Fig. 3 shows 
a  representative chromosomal spread  from fusion  27.  These results,  taken  together 
with  the  phenotypie analysis  of OKT3,  strongly  suggest  that  the  majority of the 
cultures from many of these fusions contain hybrid cells derived from the fusion of 
normal T  cells with mutant CEM-T 15 cells. 
Helper Function Analysis of Human  T  Cell Hybrids.  To  determine  whether  these 
growing  T  cell  hybrids  maintained  functions  known  to  be  present  in  the  normal 
mature parent T  cells, cultures from fusions 26 and 27 were analyzed for polyclonal 
induction of antibody production by B cells. In these experiments, growing hybrids 
were  added  to  purified  B  cells  in  the  presence  of PWM,  and  PFC  activity  was 
measured 6 d later. Controls included normal helper T cells (OKT4  ÷) as well as CEM 
and  CEM-T15  mutant  cells.  As shown in  Fig.  4,  CEM  and the mutant  CEM-T15 
cells did not generate helper activity. Furthermore, CEM-T15 inhibits the background 
level of PFC generated in cultures containing B cells and PWM. In marked contrast, 
several different hybrid cultures from both fusions expressed helper activity. 
Stability and Cloning of  Human Helper T Cell Hybrids.  To assess the functional stability 
of the helper T  cell hybrids, four hybrid cultures were periodically tested for helper 
activity over 20 wk of continuous culture (Table II). As can be seen, these uncloned 
hybrid cultures maintained helper activity for 13 wk. However, by 20 wk the majority 
of the CUJ~taares had  lost function. This loss  of activity could be secondary to either 
overgrowth  by  nonfunctional cells  or,  alternatively,  by  functional  instability  of a 
fraction of the cells. To address these possibilities the functional hybrids were cloned 
at  limiting  dilution  early  during  culture  (as  soon  as  helper  function  could  be 
FIG. 3.  Representative  chromosomal  spreads from (A) CEM-T15 TG-resistant  human T cell line; 
(B) 27.47 human T cell hybrid. 1832  GENERATION  OF  FUNCTIONAL  HUMAN T  CELL HYBRIDS 
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Fic. 4.  Human T  cell hybrids with  helper function in the  polyclonal induction of antibody 
production by B cells. Each bar represents an individual T cell hybrid (105 cells) cultured with B 
cells and PWM. After 6 d, the cultures were harvested and assayed for PFC. The negative controls 
included B cells cultured with PWM in the absence of T cells or with PWM in the presence of 
CEM-TI5 or CEM cell lines. The positive control consisted of B cells cultured with PWM in the 
presence of OKT4  + T cells. 
Fin. 6.  Helper activity of the human T cell hybrid clone 436. Graded numbers of 436 cells were 
added to B cells and PWM. After 6 d, the cultures were harvested and assayed for PFC. The 
negative control consisted of B cells cultured with PWM in the absence of hybrid cells. 
TABLE II 
Functional Assessment of Human  T Cell Hybrids 
PFC per  l0  s B cells 
Cells added to B cells 
Weeks after fusion 
and PWM 
6  7  8  13  20 
None  75  380  15  520  150 
CEM-T15  0  60  30  0  90 
26.17  410  930  530  2,640  20 
26.23  700  460  ND*  920  130 
26.59  830  750  480  1,240  105 
27.02  440  330  700  1,630  440 
* Not done. 
demonstrated)  and functional clones were subsequently recloned (Table III). Every 
clone was given a  number which followed the number of the culture of origin. For 
example, the hybrid 26.17 was cloned by limiting dilution in microtiter plates at  a 
concentration of one cell every five wells. After 3 wk, all of the growing cells (23% of 
the total) were tested for helper activity. As seen in Table III, 9% had helper activity. 
One  of  these  clones,  designated  26.17.115,  was  recloned  by  limiting dilution  as 
described above. After 4 wk,  13% of the wells contained growing cultures. In contrast 
with the relatively low percentage of helper cultures after the first cloning procedure, 
recloning of a  positive culture resulted  in 62%  of clones with  helper  activity. The 
results of these cloning experiments suggest that the frequency of helper hybrids and 
therefore functional stability increases as cloning proceeds. 
Interestingly, when the chromosome number was reassessed at 20 wk, many of these 
hybrids and their clones had a  predominantly diploid karyotype, with some of them 
having only a small percentage ofpolyploid cells. This indicates that despite significant IRIGOYEN ET  AL.  1833 
Clone source 
TABLE  III 




Wk after fusion 
14-15  18-21 
Number  Number 
tested:~  Helpers  tested  Helpers 
26.23.1  +  21  10 
26.23.1.24  + 
26.17  +  32  9 
26.17.115  + 
27.2  -  33  18 
27.2.63 
27.2.122 
44  32 
24  62 
36  39 
24  75 
* Analyzed by immunofluorescence in a cytofluorograph 19 wk after fusion. 
The individual clones (10  s) were added  to  106 B cells  plus PWM and PFC 
were measured in a reverse hemolytic plaque assay after 6 d in culture. 
loss of chromosomes during the first few months in culture, many of the diploid clones 
have  retained  genes  encoding  for  helper  activity.  One  example  is  a  clone  from 
26.17.115, designated 436, which was chosen for further analysis. The clone 436 cells 
were evaluated for chromosome number, reactivity with OKT3 and helper function 
(Figs.  5  and  6).  This  clone  has  46  chromosomes  and  is  OKT3  ÷.  Furthermore, 
functional activity was maintained since graded numbers of 436 T  cell hybrids added 
to B  cells plus  PWM  induce a  PFC  response  (Fig.  6).  Taken  together, these  data 
indicate that functional stability of these human T  cell hybrids can be preserved and 
consolidated by early and repeated cloning of the relevant hybrids. 
Discussion 
In this report we demonstrate that human T  cell hybrids can be created by fusion 
of normal, lectin-activated human T  ceils with a TG-resistant, aminopterin-sensitive 
human T  cell line. Our strategy was to (a) derive a variety of TG-resistant, aminop- 
terin-sensitive mutants from the continuously growing T  cell line CEM; (b) fuse those 
mutants with lectin-activated OKT3  ÷ human T  cells; and (c) select rapidly growing 
cultures that had survived HAT treatment for expression of the OKT3 differentiation 
antigen and for their capacity to polyclonally induce B cell differentiation. 
It is of interest that, under our culture conditions, we did not observe the reported 
growth inhibition of CEM by thymidine (23, 24). More important, the comparison of 
the  CEM  line  with  one  of  its  TG-resistant  mutants,  CEM-T15,  for  growth  in 
aminopterin-containing  medium  showed  a  narrow,  although  clear  difference  in 
aminopterin susceptibility. By carefully selecting appropriate combinations of ami- 
nopterin  concentration  and  length  of exposure,  we  were  able  to  minimize  the 
possibility of outgrowth of CEM-T15 cells yet allow the recently created hybrids to 
grow in HAT medium. Because of our interest in obtaining functional T  cell hybrids 
and  also  in  discarding any surviving CEM-T15  ceils, our initial screening strategy 
selected for cells expressing the OKT3 differentiation antigen. This surface antigen is 
not expressed on non-T ceils nor on the CEM-T15 mutant line, but it is expressed on 
85-95% of mature T  cells and on virtually all normal helper T  cells. This screening 1834  GENERATION OF  FUNCTIONAL HUMAN T  CELL HYBRIDS 
Fic.  5.  Cytofluorografic  analysis of the T cell hybrid clone 436 for reactivity with the OKT3 
monoclonal antibody. The negative control consisted of 436 cells incubated with ascites. 
was  done  5  wk  after  fusion,  at  which  time  the  possibility  of survival  of normal 
peripheral T  cells is highly unlikely. Thus,  most of the growing cells expressing the 
OKT3 antigen most likely represent hybrids between an OKT3-bearing T  cell and a 
CEM-T15  mutant  cell  that  has  permanent  growth  potential  but  does  not  express 
OKT3.  Evidence  for  hybridization  was  also  obtained  from  chromosomal  analysis 
after  10  wk  of culture,  which  demonstrated  that  most  of the  cultures  contained 
polyploid cells. 
Additional  evidence for successful hybridization resulted  from functional analysis 
of several of these cultures.  Our results clearly demonstrate that  a  proportion of the 
cultures contain helper cells. Thus, in the two separate fusions tested, human T  cell 
hybrids  were  generated  that  were  capable  of inducing  B  cell  differentiation  into 
antibody-producing cells. The helper activity generated by these hybrids is even more 
striking in light of the fact that the parental mutant line CEM-T15 does not provide 
helper activity and, indeed, consistently inhibits B cell differentiation  (Fig. 3 and O. 
Irigoyen et  al.,  manuscript  in  preparation).  We  infer  that  following  hybridization, 
genes  coding  for  helper  activity  or,  alternatively,  for  inactivation  of  inhibitory IRIGOYEN ET AL.  1835 
mechanisms  have been transferred from the normal T  cell into the  genome of the 
CEM-T 15 mutant. 
The functional stability of these helper T  cell hybrids was assessed both by periodic 
testing for helper function and, more importantly, by repeated cloning of functioning 
hybrids. An important point to emerge from these studies is that early and repeated 
cloning is important for the preservation of functional stable hybrids. For example, 
uncloned functional hybrids begin to lose activity after 13 wk of continuous culture. 
In  contrast,  clones  derived  from  these  same  hybrids  early  in  culture  give  rise  to 
progenies with stable functional activity. Interestingly, functional stability is main- 
tained despite significant loss of chromosomes after 10 wk of culture. For example, the 
diploid clone 436 has been in culture for >21 wk and still expresses the OKT3 surface 
antigen and maintains high levels of helper activity. 
In summary, these experiments demonstrate that functional human T  cell hybrids 
can be created by fusion of normal PHA-activated T  cells with CEM-TI5 mutant 
cells. These functional hybrids can be repeatedly cloned and maintain stable func- 
tional activity. Experiments are now ongoing to determine whether antigen-activated 
human  T  cells can  be fused with  CEM-T15  in  an  analogous  manner to construct 
antigen-specific human T  cell hybrids with distinct functional activities. These cells 
and their products will be of considerable interest with respect to further studies of 
the immunobiology of human T  cells. 
Summary 
Human  T  cell  hybrids  were  generated  by  fusing  lectin-activated  normal  and 
leukemic human T cells with an aminopterin-sensitive human T cell line. This mutant 
cell line, designated CEM-T15, was derived from the human T  cell line CEM after 
chemical mutagenesis with ethane methylsulfonate and subsequent culture in medium 
containing 6-thioguanine.  After  polyethylene glycol-induced fusion,  the  cells  were 
cultured in hypoxanthine-aminopterin-thymidine selective medium. More than 5 wk 
after fusion, evidence for successful hybridization was obtained by three independent 
criteria: (a) The majority of the cultures contained cells expressing the OKT3 surface 
antigen:  this antigen is expressed on normal T  cells but not on CEM-T15 ceils.  (b) 
Most  of the cultures  contained  polyploid cells.  (c)  Some of the cultures  provided 
helper activity in the generation of antibody-forming cells. This functional activity is 
absent from the CEM-T15 parental cell line. Evidence for functional stability of the 
hybrids >20 wk after fusion was provided by several clones that  not only continue 
growing exponentially but  also  maintain  expression of OKT3 surface antigen  and 
high levels of helper function. These T  cell hybrids and similar hybrids constructed 
using antigen-specific human T  cells should be of considerable importance in further 
studies of the immunobiology of human T  cells. 
Received  for publication 15June 1981. 
References 
1.  Morgan,  D.  S.,  F.  W.  Fuscetti,  and  R.  C.  Galto.  1976. Selective  m vitro growth of T 
lymphocytes from normal human bone marrows. Science (Wash. D. C.). 193:1007. 
2.  Gillis, S., and K. A. Smith.  1977. Long-term culture of tumor-specific  cytotoxic T  cells. 
Nature (  Lond.  ). 268:154. 1836  GENERATION OF FUNCTIONAL HUMAN T  CELL HYBRIDS 
3.  Friedman, S. M., Y. Thomas, O. H. Irigoyen, and L. Chess.  1981. Hapten specific human 
T cell lines. In New Trends in Human Immunology and Cancer Immunotherapy. B. Serou 
and C. Rosenfeld, editors. Editions Doin, Paris.  116. 
4.  Fresno, M., G. Nabel, L. McVay-Boudreau, H. Furthmayer, and H. Cantor. 1981. Antigen- 
specific T lympocyte clones. I. Characterization ofa T lympocyte clone expressing antigen- 
specific suppressive activity.J. Exp. Med.  153"1246. 
5.  Kohler, G., and C. Milstein.  1975. Continuous cultures of fused cells secreting antibody of 
predefined specificity.  Nature (Lond.). 256:495. 
6.  Goldsby, R. A., B. A. Osborne, E. Simpson, and L. A. Herzenberg.  1977. Hybrid cell lines 
with T-cell characteristics. Nature (Lond.). 267:707. 
7.  Kontiainen,  S.,  E.  Simpson,  E.  Bohrer,  P.  C.  L.  Beverley,  L.  A.  Herzenberg,  W.  C. 
Fitzpatrick, P. Vogt, A. Torano, I. F. C. McKenzie, and M. Feldman.  1978. T-cell lines 
producing antigen-specific suppressor factor. Nature (Lond.). 274:477. 
8.  Taniguchi,  M.,  and J.  F.  A.  P.  Miller.  1978. Specific suppressor  factors  produced  by 
hybridomas derived from the fusion of enriched suppressor T  cells and T  lymphoma cell 
line.J.  Exp.  Med.  1441:373. 
9.  Taussig, M. J., J. R. F. Corvalan, R. M. Binns, and A. Holliman.  1979. Production of an 
H-2-related suppressor factor by a hybrid T-cell line. Nature (Lond.). 277:305. 
10.  Kapp, J.,  B. A. Araneo, and B.  L. Clevinger.  1980. Suppression of antibody and T  cell 
60  30  10  proliferative responses  to L-glutamic acid  -h-alanine  -L-tyrosine  by a specific monoclonal 
T  cell factor.,]. Exp. Med.  152:235. 
11.  Harwell,  L.,  B.  Skidmore,  P.  Marrak,  and J.  Kappler.  1980. Concanavalin A-inducible 
interleukin-2-producing T cell hybridoma.J. Exp.  Med.  152:893. 
12.  Eshhar,  Z.,  R.  N.  Apte,  I.  Lowy, Y,  Ben-Neriah,  D.  Givol, and  E.  Mozes.  1980. T-cell 
hybridoma bearing heavy chain variable region determinants producing (T,G)-A--r-specific 
helper factor. Nature (Lond.). 286:270. 
13.  Kaufman, Y., G. Berke,  and Z. Eshhar.  1981. Cytotoxic T  lymphocyte hybridomas that 
mediate specific tumor-cell lysis in vitro. Proc. Natl.  Acad. Sci. U. S. A. 78.'2502. 
14.  Kung,  P.  C.,  G.  Goldstein,  E.  L.  Reinherz,  and  S.  F.  Schiossman.  1979. Monoclonai 
antibodies defining distinctive human T cell surface antigens. Science (Wash. D. C.) 206:347. 
15.  Epstein, J., A. Leyva, W. N. Kelly, and J. W. Littlefield.  1977. Mutagen-induced diploid 
human  lymphoblast  variants  containing  altered  hypoxanthine  guanine  phosphoribosyl 
transferase. Somatic Cell Genet. 3:135. 
16.  Chess,  L.,  R.  P.  MaeDermott,  and  S.  F.  Schlossman.  1974. Immunologic functions  of 
isolated human lymphocyte subpopulations. I. Quantitative isolation of human T  and B 
cells and response to mitogens. J. Immunol. 113:1113. 
17.  Thomas, Y.,J. Sosman, O. H. Irigoyen, S. M. Friedman, P. C. Kung, G. Goldstein, and L. 
Chess.  1980. Functional analysis of human T cell subsets defined by monoclonal antibodies. 
I.  Collaborative T-T  interactions  in  the  immunoregulation  of B cell  differentiation. J. 
Immunol. 125:2402. 
18.  Galfre, G., S. C. Howe, C. Milstein, G. W. Butcher, andJ. C. Howard. t977. Antibodies to 
major histocompatibility antigens produced by hybrid cell lines. Nature (Lond.). 266:550. 
19.  Gefter, M. L., D. H. Margulies, and M. D. Scharff. 1977. A simple method for polyethylene 
glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet. 3:231. 
20.  Sharon, J., S. L. Morrison, and E. A. Kabat.  1980. Formation of hybridoma clones in soft 
agarose: effect of pH and of medium. Somatic Cell Genet. 3:435. 
21.  Thomas, Y., L. Rogozinski, O. H. Irigoyen, S. M. Friedman, P. C. Kung, G. Goldstein, and 
L.  Chess.  1981. Functional  analysis  of human  T  cell  subsets  defined  by  monoclonal 
antibodies.  IV. Induction of suppressor cells within the OKT4  + population, j. Exp.  Med. 
154:459. IRIGOYEN ET AL.  1837 
22.  Mellman,  W.J. 1965. Human peripheral  blood leukocyte cultures. In Human Chromosome 
Methodology. J. J. Yunis, editor. Academic Press, Inc. N. Y. 21. 
23.  Schachtschabel,  D. O., H. Lazarus, S. Farber, and G. E. Foley. 1966. Sensitivity of cultured 
human lymphoblasts  (CCRF-CEM cells) to inhibition  by thymidine. Exp. Cell Res. 43:512. 
24.  Fox, R. M., S. K. Piddington,  E. H. Tripp, and M. H. N. Tattersal.  1981. Ecto-Adenosine 
triphosphatase  deficiency in cultured human T  and null  leukemic lymphocytes. J.  Clin. 
Invest. 68:544. 